Product
Acetylcholine
8 clinical trials
18 indications
Indication
AnemiaIndication
Hot FlashesIndication
MenopauseIndication
Vasomotor SystemIndication
PreeclampsiaIndication
Endothelial FunctionIndication
OestrogenIndication
Cardiovascular DiseasesIndication
MicrovasculatureIndication
Chronic Obstructive Pulmonary DiseaseIndication
Pulmonary Arterial HypertensionIndication
Congestive Heart FailureIndication
HypertensionIndication
chronic kidney diseaseIndication
Spinal Cord InjuriesIndication
Endothelial dysfunctionIndication
VasodilationIndication
Oral Soft Tissue ConditionsClinical trial
A Randomized, Repeat Dose, Open Label, Parallel Group, Multi-center Study to Evaluate the Effect of Daprodustat Compared to Darbepoetin Alfa on Forearm Blood Flow in Participants With Anemia of Chronic Kidney Disease That Are Not Dialysis DependentStatus: Terminated, Estimated PCD: 2019-05-29
Clinical trial
Hot Flashes and Neurovascular Function in WomenStatus: Recruiting, Estimated PCD: 2025-12-01
Clinical trial
Protective Mechanisms of Prenatal Aspirin Therapy on Maternal Vascular Dysfunction Following PreeclampsiaStatus: Recruiting, Estimated PCD: 2025-03-31
Clinical trial
Sex-specific Effects of Continuous Estrogen on Human in Vivo Microvascular FunctionStatus: Recruiting, Estimated PCD: 2029-12-01
Clinical trial
Vascular Function in Health & Disease: Rehabilitation for Hypertension; Exercise and Skeletal Muscle Afferent FeedbackStatus: Recruiting, Estimated PCD: 2025-08-01
Clinical trial
An Observational, Open-label Pilot Study to Evaluate the Effect of Standard-of-care Erythropoiesis-stimulating Agents (Darbepoetin Alfa) on Forearm Blood Flow in Nondialysis-dependent Subjects With Anaemia Associated With Chronic Kidney Disease.Status: Completed, Estimated PCD: 2018-05-21
Clinical trial
Role of Vascular Endothelial Function After Spinal Cord Injury Related Cardiovascular Disease RiskStatus: Recruiting, Estimated PCD: 2027-03-30
Clinical trial
Investigation of Endothelium-dependent Vasodilation in Human Gingiva Depending on Serum Estrogen LevelStatus: Active (not recruiting), Estimated PCD: 2024-12-31